Year |
Citation |
Score |
2017 |
Zhu B, Lindsey A, Li N, Lee K, Ramirez-Alcantara V, Canzoneri JC, Fajardo A, Madeira da Silva L, Thomas M, Piazza JT, Yet L, Eberhardt BT, Gurpinar E, Otali D, Grizzle W, et al. Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signaling. Oncotarget. 8: 69264-69280. PMID 29050202 DOI: 10.18632/Oncotarget.20566 |
0.383 |
|
2016 |
Fajardo AM, MacKenzie DA, Olguin SL, Scariano JK, Rabinowitz I, Thompson TA. Antioxidants Abrogate Alpha-Tocopherylquinone-Mediated Down-Regulation of the Androgen Receptor in Androgen-Responsive Prostate Cancer Cells. Plos One. 11: e0151525. PMID 26986969 DOI: 10.1371/Journal.Pone.0151525 |
0.548 |
|
2015 |
Fajardo AM, Piazza GA. Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention. American Journal of Physiology. Gastrointestinal and Liver Physiology. 309: G59-70. PMID 26021807 DOI: 10.1152/Ajpgi.00101.2014 |
0.344 |
|
2015 |
Li N, Lee K, Xi Y, Zhu B, Gary BD, Ramírez-Alcántara V, Gurpinar E, Canzoneri JC, Fajardo A, Sigler S, Piazza JT, Chen X, Andrews J, Thomas M, Lu W, et al. Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activity. Oncogene. 34: 1499-509. PMID 24704829 DOI: 10.1038/Onc.2014.94 |
0.403 |
|
2015 |
Fajardo AM, Browne T, Graff H, Kleier K, Neltner K, McCall C, Meyer B, Douglass L, Carter J. Abstract 1024: Targeting PAK1 activity in breast cancer: Inhibition of cell growth, survival, motility, and signaling Cancer Research. 75: 1024-1024. DOI: 10.1158/1538-7445.Am2015-1024 |
0.487 |
|
2014 |
Fajardo AM, Piazza GA, Tinsley HN. The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatment. Cancers. 6: 436-58. PMID 24577242 DOI: 10.3390/Cancers6010436 |
0.431 |
|
2014 |
Russo S, Li N, Lee K, Xi Y, Zhu B, Gary B, Ramirez V, Gurpinar E, Canzeroni J, Fajardo A, Sigler S, Piazza JT, Chen X, Andrews J, Li Y, et al. Phosphodiesterase 10, a novel target in colon cancer. Journal of Clinical Oncology. 32: 503-503. DOI: 10.1200/Jco.2014.32.3_Suppl.503 |
0.421 |
|
2014 |
Chen X, Lee KJ, Gary BD, Canzoneri JC, Fajardo AM, Sigler SC, Ramirez-Alcantara V, Zhu B, Piazza GA, Keeton AB. Abstract B39: A novel series of substituted indene derivatives that potently and selectively inhibit growth of tumor cells harboring mutant Ras Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Rasonc14-B39 |
0.36 |
|
2014 |
Fajardo AM, Gary BD, Lee KJ, Keeton AB, Zhu B, Chen X, Abadi AH, Piazza GA. Abstract 2322: β-catenin-dependent TCF/LEF transcriptional regulation of phosphodiesterase expression in colon cancer cells Cancer Research. 74: 2322-2322. DOI: 10.1158/1538-7445.Am2014-2322 |
0.457 |
|
2014 |
Li N, Lee K, Xi Y, Zhu B, Gary BD, Ramírez-Alcántara V, Gurpinar E, Canzoneri JC, Fajardo A, Sigler S, Piazza JT, Chen X, Andrews J, Lu W, Li Y, et al. Abstract 1773: Phosphodiesterase 10A: A novel target for selective inhibition of colon tumor cell growth and Wnt/β-catenin signaling Cancer Research. 74: 1773-1773. DOI: 10.1158/1538-7445.Am2014-1773 |
0.441 |
|
2014 |
Zhu B, Li N, Ramirez-Alcantara V, Canzoneri J, Gurpinar E, Fajardo A, Lee K, Sigler S, Gary B, Thomas M, Keeton A, Chen X, Grizzle W, Piazza G. Abstract 1761: PDE10, a novel therapeutic target for lung cancer Cancer Research. 74: 1761-1761. DOI: 10.1158/1538-7445.Am2014-1761 |
0.406 |
|
2014 |
Fajardo AM, Bisoffi M. Curcumin Analogs, Oxidative Stress, and Prostate Cancer Cancer: Oxidative Stress and Dietary Antioxidants. 191-202. DOI: 10.1016/B978-0-12-405205-5.00018-0 |
0.599 |
|
2013 |
Li N, Lee K, Xi Y, Zhu B, Gary BD, Ramirez-Alcantara V, Gurpinar E, Canzoneri J, Fajardo A, Sigler S, Piazza JT, Chen X, Andrews J, Thomas M, Lu W, et al. Abstract C182: Phosphodiesterase 10: A novel cancer target. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-C182 |
0.435 |
|
2012 |
Fajardo AM, MacKenzie DA, Ji M, Deck LM, Vander Jagt DL, Thompson TA, Bisoffi M. The curcumin analog ca27 down-regulates androgen receptor through an oxidative stress mediated mechanism in human prostate cancer cells. The Prostate. 72: 612-25. PMID 21796654 DOI: 10.1002/Pros.21464 |
0.661 |
|
2011 |
Fajardo AM, MacKenzie DA, Deck LM, Jagt DLV, Thompson TA, Bisoffi M. Abstract 2073: Curcumin analog 27 induced reactive oxygen species mediate loss of androgen receptor protein expression in human prostate cancer cells Cancer Research. 71: 2073-2073. DOI: 10.1158/1538-7445.Am2011-2073 |
0.649 |
|
2010 |
Fajardo AM, Bowles HJ, MacKenzie DA, Jagt DLV, Bisoffi M, Thompson TA. Abstract 1713: Activation of the aryl hydrocarbon receptor and down-regulation of the androgen receptor in prostate cancer cells by the curcumin analog C48 Cancer Research. 70: 1713-1713. DOI: 10.1158/1538-7445.Am10-1713 |
0.656 |
|
2005 |
Hines WC, Fajardo AM, Joste NE, Bisoffi M, Griffith JK. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues. Molecular Cancer Research : McR. 3: 503-9. PMID 16179497 DOI: 10.1158/1541-7786.Mcr-05-0031 |
0.571 |
|
Show low-probability matches. |